CliffBio
small molecule

HECTOROL

DOXERCALCIFEROL

Loss of exclusivityJune 2028FDA regulatory exclusivity expiry
CompanySanofi Genzyme →See this company's full patent-cliff portfolio

Drug detail

Brand nameHECTOROL
Active ingredientDOXERCALCIFEROL
Strength2.5MCG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJune 1999
Marketing statusDISCN

Regulatory exclusivity

CodeExpires
M-14June 2028

More from Sanofi Genzyme

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.

HECTOROL patent cliff — loss of exclusivity June 2028 | CliffBio